Kiki Freedman is the CEO and Co-founder of Hey Jane, which she founded while at Harvard Business School. Prior to business school, Kiki was an early employee at Uber, where she took on a variety of roles including launching Uber in Kenya, spearheading key operational
initiatives on the company’s PRO team, and leading Strategy + Expansion for UberEats in the Middle East and Africa (MEA) region. She started her career as an Associate Consultant at Bain & Co, and graduated magna cum laude from Washington University with double majors in Economics and International Development.

Rem Koning is an Assistant Professor in the Strategy Unit at Harvard Business School. He studies how entrepreneurs build their firms and how to broaden the benefits of startup growth and innovation. His case writing and academic work have explored how entrepreneurs experiment and learn from one another in numerous contexts, including technology startups, women’s health, firm hiring, entrepreneurship in developing economies, mental health, and scientific innovation.

Professor Koning earned degrees in mathematics and statistics from the University of Chicago and his Ph.D. at the Stanford Graduate School of Business, where he received a Kauffman Dissertation Fellowship. He teaches strategy and entrepreneurship to both executives and MBA students. His work has appeared in Science, the Strategic Management Journal, Management Science, Research Policy, Organization Science, and the American Sociological Review. It has been covered by the Wall Street Journal, STAT News, Nature, Vox, and the New York Times.

Dr. Liz Kwo has 20+ years of experience in building digital health and medical management companies, with a focus on using data analytics to transform health and wellness at scale. Currently she is the Chief Medical Officer of Everly Health, the digital health company at the forefront of the $300 billion virtual diagnostics-driven care industry, with an aim to provide consumers access to at-home lab tests that include insightful, easy-to-understand results. Most recently, Dr. Kwo served as Deputy Chief Clinical Officer for Elevance (NYSE: ELV) to modernize disease management and care delivery for 43 million Americans covered under Medicare, Medicaid, and Commercial businesses. Prior to Elevance, Dr. Kwo started several venture backed companies as the CEO and co-founder of InfiniteMD (acquired by Consumer Medical, subsequently acquired by Alight (NYSE: ALIT) and President and co-founder of New Pathway Education and Technology Group (acquired by EIC Education). Her prior healthcare work includes supporting innovation at American Well (NYSE: AMWL), Medtronic (NYSE: MDT), and Third Rock.

Dr. Kwo is on the Board of Directors of Asensus (NYSE AMERICAN: ASXC), Walmart Mexico and Central America (Mexican Stock Exchange/BMV: WALMEX), BlueWind Medical and ChroniSense. 

Dr. Kwo continued to see patients in urgent care at Cambridge Health Alliance Hospital, teach residents as a faculty lecturer at Harvard Medical School, and is board certified in Preventive Care and Occupational Medicine. She earned a BA in Human Biology from Stanford University, MD from Harvard Medical School, MBA from Harvard Business School, and an MPH from Harvard T.H. Chan School of Public Health. 

Michael Langer is Head of Search, Evaluation & In-licensing/ Acquisitions at Pear Therapeutics (NASDAQ: PEAR). Michael reports to Pear's Founder and CEO Dr. Corey McCann. Pear Therapeutics discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has raised over $400M and recently went public via SPAC.

Michael also founded a fund called Old Silver VC which is a family-associated investment firm that invests in startups in Healthcare and Deep Tech with a focus on materials. To date, they have invested in over 20 companies including Big Hat Biosciences, ATAI Life Sciences, Seismic Therapeutics, Alto Pharmacy and Opentrons. He currently is Co-founder and General Partner at a new fund called Harvest.Bio which is investing in next generation companies at the intersection of biotech and tech.

Michael is an active philanthropist. He co-founded the Young Coder's Society which teaches children how to code using Raspberry Pi's. He is a World Economic Forum Global Shaper and a Young Leader at the Milken Institute. He serves on The Leadership Board at Beth Israel Deaconess Medical Center, on the Board of Advisors at the Museum of Science and is the Senior Advisor of Special Projects at the Galenus Foundation.

Sachin (pronounced SUCH-in) H. Jain, MD, MBA is President and CEO of SCAN Group and Health Plan, where he is charged with leading the organization’s growth, diversification, and emerging efforts to reduce healthcare disparities. SCAN’s revenues top $3.4B and the organization serves 220,000 patients.

Previously, Dr. Jain was President and CEO of CareMore and Aspire Health, innovative care delivery systems with > $1.6B in revenues serving 200,000 Medicare and Medicaid patients and 2500 associates in 32 states. He pioneered the first clinical program in the world focused on social isolation. Dr. Jain is also an adjunct professor of medicine at the Stanford University School of Medicine and a contributor at Forbes.

Prior to joining CareMore, Dr. Jain was global Chief Medical Information & Innovation Officer at Merck & Co. He contemporaneously served as an attending physician at the Boston VA-Boston Medical Center and a member of faculties at Harvard Medical School and Harvard Business School. From 2009-2011, Dr. Jain worked in leadership roles at the US Department of Health and Human Services, where he was senior advisor to the administrator of the Centers for Medicare & Medicaid Services (CMS). Dr. Jain was the first acting deputy director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI). He also served as special assistant to the National Coordinator for Health Information Technology.

Dr. Jain is a respected thought leader in health care delivery. He is regularly recognized as a “Top 50 Most Influential Clinical Leader” and “100 Most Influential People in US Healthcare” by Modern Healthcare. In 2018, LinkedIn named him its top voice (#1) for healthcare.

Dr. Jain graduated magna cum laude from Harvard College with a BA in government and continued on to earn his MD from Harvard Medical School and MBA from Harvard Business School. He is a member of the Board of Directors of Abode Hospice and and the Make-A-Wish Foundation. He trained in medicine at the Brigham and Women's Medicine and Harvard Medical School, earned his board certification from the ABIM, and continues to practice medicine. He is co-founder and co-editor-in-chief of the Elsevier journal Healthcare: The Journal of Delivery Science & Innovation and is an elected member of the National Academy of Social Insurance (NASI). He is an Aspen Institute Health Innovator’s Fellow and a Paul and Daisy Soros Fellow.

Born in 1980, he is a native of New Jersey, but presently resides in Los Angeles, California.

Robert Huckman is the Albert J. Weatherhead III Professor of Business Administration at Harvard Business School, the Howard Cox Faculty Chair of the HBS Healthcare Initiative, and the Unit Head for Technology and Operations Management. He currently teaches the second-year MBA course entitled Transforming Health Care Delivery and has previously taught both required and elective courses in Technology and Operations Management. Professor Huckman is the Faculty Chair of HBS' executive education program entitled Managing Health Care Delivery.  He is also a Research Associate at the National Bureau of Economic Research and the Co-Chair of the management track of Harvard's doctoral program in health policy.

Professor Huckman's research focuses on the linkages between organizational characteristics and operating performance, with an emphasis on the health care industry. He is an associate editor of Management Science and has published articles in journals including the American Economic Review, Harvard Business Review, Health Affairs, the Journal of the American Medical Association, Management Science, and the New England Journal of Medicine. Professor Huckman also serves as a Trustee of the Brigham and Women's Physicians Organization and Brigham Health as well as an advisory board member for several private companies in the health care industry.

Professor Huckman received a Ph.D. in Business Economics from Harvard University and an A.B. in Public Policy, summa cum laude, from Princeton University, where he was elected to Phi Beta Kappa.

Prior to his graduate studies, Professor Huckman was a Principal and Founding Equity Member of Stamos Associates, Inc., a strategy and operations consulting firm serving clients in the health care industry. In 1997, Stamos Associates was acquired by Perot Systems, Inc. Professor Huckman has also worked at Booz Allen & Hamilton, Inc.